Doctor Care Anywhere Group PLC · ASX:DOC

Doctor Care Anywhere — FY2023 Earnings Presentation

14 slides from Doctor Care Anywhere's earnings presentation, Feb 29, 2024

  1. Slide 1: FY23 Preliminary Results

    Doctor Care For personal use only Anywhere Transforming lives through better healthcare FY23 Preliminary Results 29 February 2024 1 © 2023 Doctor Care Anywhere

  2. Slide 2: Important Notice and Disclaimer

    Important Notice and Disclaimer This presentation is for information purposes only and it is not indicated. A number of figures, amounts, percentages, estimates, performance cannot be relied upon as a guide to future financial product or investment advice. The presentation is not calculations of val

  3. Slide 3: DCA is one of the UK's largest private providers of telehealth services

    DCA is one of the UK’s largest private providers of telehealth services We work with health insurers, healthcare providers and corporate customers to connect patients to a range of digitally enabled telehealth services on our proprietary platform Appointments with GPs and ANPs Referrals – diagnostic

  4. Slide 4: Multi-channel Distribution of Our Services

    Multi-channel Distribution of Our Services We use a successful B2B2C delivery model and partnerships through multiple channels to deliver services to corporate clients and members Insurers Health providers Employee engagement platforms Direct relationships For personal use only Serving 1,500+ organi

  5. Slide 5: 2023 Executive Summary

    2023 Executive Summary FY23 highlights 19% increase • Launch of Mixed Clinical Workforce, with Advanced in consultations on Nurse Practitioners live on platform from June 2023, helping to address capacity constraints and reduce FY22; totalling cost to serve For personal use only 731,000 • Gross marg

  6. Slide 6: FY23 Results Overview

    FY23 Results Overview £38.5m 730,600 535,000 For personal use only Revenue(A$72.6m) consultations delivered consultations delivered to returning patients +31% on FY22 +19% on FY22 Demonstrating quality and retention value of service EBITDA loss 46.0% reduced to Gross Profit Margin Up 4ppt on FY22, s

  7. Slide 7: Key Metric Overview

    Key Metric Overview For personal use only Consultations by quarter Revenue by quarter (£m’s)* *. All revenue figures exclude GP2U Returning patients New patients Activated Lives by quarter (000’s) Returning patient percentage FY23 7 © 2024 Doctor Care Anywhere

  8. Slide 8: Profit and loss

    Profit and loss £ in millions FY23 FY22 Variance % 2H 23 1H 23 Variance % Utilisation revenue 36.0 27.1 8.9 32.8% 18.1 17.9 0.3 1.4% Subscription revenue 2.5 2.2 0.3 12.1% 1.2 1.3 (0.1) (8.0%) Revenue 38.5 29.3 9.1 31.2% 19.3 19.2 0.1 0.8% Cost of sales (20.8) (17.0) (3.8) (22.2%) (10.0) (10.8) 0.9

  9. Slide 9: FY23 financial performance analysis

    FY23 financial performance analysis Revenue growth in year Revenue for FY23 was £38.5 million (A$72.6 million), up 31.2% on FY22 • Growth driven by increase in consultations and annual price increases Improvement in gross margin and contribution margin For personal use only Gross profit margin for F

  10. Slide 10: Cash flow vs. EBITDA

    Cash flow vs. EBITDA • Operating cash outflow has historically tracked EBITDA on a half yearly basis • 1H 22 and 2H 22: Cost base reduced driven by restructuring exercise with associated one-off costs in 1H, leading to improved results in 2H For personal use only • Both operating cashflow and EBITDA

  11. Slide 11: Balance sheet

    Balance sheet £ in thousands FY23 FY22 Variance % Property, plant and equipment 747 1,220 (473) (38.8%) Intangible assets 5,968 9,131 (3,163) (34.6%) Interest in joint venture - 1,966 (1,966) (100.0%) • Intangible assets down by £1.9m due to sale of Investments 1,300 GP2U in year, with £1.3m investm

  12. Slide 12: Market guidance update

    Market guidance update • The Company achieved all market guidance targets for 2023 and is on track for EBITDA breakeven in Q1 2024 Metric FY23 guidance Status Annualised revenue run rate 1H23 end £42-46m Met For personal use only Gross margin 50-55% by 2H23 end Met Contribution margin 35%-40% by 2H2

  13. Slide 13: FY24: Look ahead

    FY24: Look ahead Balance sheet strengthened • The recently issued £10.6m convertible loan note supports the Company’s medium-term growth by enabling it to reinvest its cash resources in the business Continuing improvement in financial performance: market guidance1 • Positive EBITDA in Q1 2024 For pe

  14. Slide 14: For personal use only

    For personal use only doctor care anywhere.

Doctor Care Anywhere Group — FY2023 Earnings Presentation on 6ix